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Helicobacter pylori (H. pylori) infection has been reported in more than half of the world human population. It is 
associated with gastric inflammation and noticeable infiltration of the immune cells to the stomach mucosa by 
several cytokines secretion. IL-1β, IL-18 have been shown to contribute to H. pylori induced gastritis, but the 
details of inflammation and association of virulence factors remain unclear. IL-1 cytokine family has a new 
additional cytokine, Interleukin-33 (IL-33), which is contemplated to have an important role for host defense 
against microorganisms. H. pylori virulence factors important in gastritis risk are the cag pathogenicity island 
(cag-PAI) and babA. This study evaluated IL-33 mucosal mRNA expression levels in infected and uninfected 
patients and its relationship with bacterial virulence factors cagA, babA2 and type of gastritis. Total RNA was 
extracted from gastric biopsies of 79 H. pylori-infected patients and 51 H. pylori-negative patients. Mucosal IL-
33 mRNA expression levels in gastric biopsies were assessed using real-time PCR. Existence of virulence 
factors were detected by PCR. IL-33 mRNA expression was significantly higher in biopsies of H. pylori-infected 
patients compared to H. pylori-uninfected patients (P<0.0001). Also there was a direct relationship between 
virulence factor bab-A2 and enhancement in IL-33 mRNA expression. Furthermore, IL-33 mRNA expression 
level was significantly lower in chronic gastritis patients compared with patients with active gastritis (P<0.001). 
IL-33 may play a crucial role in the inflammatory response and induction of the chronic gastritis and severity of 
inflammatory changes in the gastric mucosa. 
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elicobacter pylori (H. pylori) is a Gram-
negative bacterium that attaches to the 
stomach epithelial cells and colonizes in the 
stomach of approximately half of the world 
population, causing long lived gastric inflammation 
despite the host immune responses. (1, 2). H. pylori 
H
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infection is associated with gastritis and immune 
cell infiltration into the gastric mucosa that may 
lead to chronic gastritis, peptic ulcer and production 
of pro inflammatory cytokines such as IL-1, IL-8, 
and TNFα (3, 4). In recent years, a newly addition 
to the IL-1 family is IL-33 which has high 
similarity to IL-18. In contrast to IL-18, IL-33 has 
anti-inflammatory effects although a TH1 response 
has been reported (5, 6). IL-33 is produced as a 30 
kD protein which is cleaved by caspase to produce 
an 18 kD form. IL-33 is highly expressed in the 
stomach epithelium. However, its gastric function is 
unknown (5). IL-33 exists in the nucleus and 
cytoplasm of macrophages, dendritic cells, 
fibroblast and endothelial cells (7). The role of IL-
33 and its receptors ST2 "IL-33/ST2" have been 
identified as crucial to the homeostasis of the 
epithelial inflammation specially in intestinal 
epithelium (8). Patients with ulcerative colitis show 
increased IL-33 levels in the epithelium of intestine 
(9). The ST2 gene relates to the IL-1/TLRs super 
family which produces four ST2 protein isoforms 
(10). In addition, serum ST2 levels are associated 
with severity of disease that may be a biomarker of 
disease degree (7, 11). Some researchers showed 
high expression level of IL-33 in endothelial cells 
and cancer cell lines (8, 12). IL-33 is known to be 
associated with inflammatory tissue in crohn’s 
disease and rheumatoid arthritis (9). Although 
virulence factors may induce gastric inflammation, 
atrophy, metaplasia and malignancy in the stomach, 
it has been reported that mucosal levels of pro-
inflammatory cytokines in the infection site with H. 
pylori are correlated with the various H. pylori 
virulence factors (13). This study evaluated IL-33 
mucosal mRNA expression levels in infected and 
uninfected patients and assessed its relationship 
with bacterial virulence factors cagA, babA2 and 
type of gastritis. 
 
Material & methods 
Patients & sampling 
130 specimens were collected from patients 
presenting dyspepsia symptoms and gastrointestinal 
disorders. The process was approved by Ethics 
Committee of Shahrekord University of Medical 
Sciences. Gastric biopsy specimens were taken 
from the antrum (pyloric gland area). Gastritis was 
investigated by endoscopy. None of the patients had 
received anticoagulants and nonsteroidal anti- 
inflammatory drugs (NSAIDs) for 1 month before 
specimen collection and none of them had received 
treatment for H. pylori infection and no 
autoimmune disease was reported (14). 79 H. pylori 
infected gastritis patients including 40 men (40.02 ± 
15.65 years) and 39 women (38.9 ± 13 years) and 
51 uninfected gastritis patients, 23 men (41.42 ± 
12.25 years) and 28 women (39.8 ± 15.02 years), 
contributed to this study. H. pylori infection was 
detected by the rapid urease test (RUT), polymerase 
chain reaction (PCR), and pathological examination 
(PE) of three biopsies taken from the antrum. 
Patients with all positive tests (RUT, PCR, PE) 
were considered as positive for H. pylori infection. 
Determination of bacterial virulence factors was 
conducted by PCR test and one biopsy from each 
case was used for measuring IL-33 mRNA 
expression rate by real-time PCR. 
Histological examination 
Gastric biopsy specimens were merged in 10% 
buffered formalin and stained with hematoxylin and 
eosin (H&E) to grade gastritis and with giemsa for 
H. pylori detection. The severity of gastritis was 
graded from 1-3 (Mild, Moderate, Severe) based on 
the degree of immune cells infiltration, polymor-
phonuclear leukocyte (PMN) and mononuclear cell 
(MNC) infiltration, and dysmorphic according to 
the updated Sydney system (15). 
Molecular characterization of H. pylori 
Genomic DNA from all samples was extracted 
by Biospin tissue genomic DNA extraction kit 
(BioFlux, Japan) PCR. Specific primers for H. 
pylori and its virulence factors PCR test were: 16S 
rRNA, forward: 5'-CTGGAGAGACTAAGCCCTC 
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C-3' and reverse: 5'-ATTACTGACGCTGATTGTG 
C-3', glmM (ureA), forward: 5'-AAGCTTTTAG 
GGGTGTTAGGGGTTT-3' and reverse: 5'-AAGC 
TTACTTTCTAACACTAACGC-3' (housekeeping 
and specific genes, respectively), cagA, forward: 5'-
ATGACTAACGAAACTATTGATC-3' and reverse 
:5'-CAGGATTTTTGATCGCTTTATT-3', babA2, 
forward:5'- CCAAACGAAACAAAAAGCGT - 3' 
and reverse: 5'-GCTTGTGTAAA AGCCGTCGT-
3' . For cagA, babA2 gene evaluation, the PCR 
program contained 35 cycles of denaturation (94 °C 
for 30 s), annealing (56 °C for 30 s, extension at 72 
°C for 30 s), and one final extension (72 °C for 5 
min) (16, 17). 
Analysis of IL-33 mRNA expression in the 
gastric mucosa samples by real-time PCR 
Total RNA was extracted from gastric biopsy 
samples by total RNA extraction biozol (bioflux, 
Japan). An aliquot containing 0.1 mg of total RNA 
was used for the reverse transcription (RT) reaction, 
according to the manufacturer’s instructions first-
strand cDNA synthesis system (Takara, Japan). The 
sequences of oligonucleotide primers and probe 
designed by Oligo.7 software for β-actin and IL-33 
are: β-actin, forward 5'-AGCCTCGCCTTTGC-
CGA-3' and reverse 5' -CTGGTGCCTGGGGCG-3' 
and probe FAM 5'-CCGCCGCCCGTCCACACC-
CGCC-3' TAMRA, for IL-33, forward 5'-
TGGAGGATGAAAGTTATGAG-3', reverse 5'-
TCAGGGTTACCATTAACATC-3', probe  FAM 
5'-TACCATCAACACCGTCACCTGATTCA-3' 
TAMRA. The assessment of IL-33 mRNA levels 
was performed using a Rotor-Gene 3000 (Corbett, 
Australia). real-time PCR reactions were done in a 
total volume of 25 µl containing 12.5 µl of 2x 
Rotor-Gene Probe PCR Master Mix (Qiagen, 
Germany), 3 µl of synthesized cDNA solution, 500 
nM of each forward & reverse primer and 250 nM 
of the TaqMan probe. Amplification process 
included a primary warming step (94 °C for 10 
min), denaturation step (94 °C for 15 s) and an 
annealing/extension step (60 °C for 60 s). Relative 
quantification of cytokine mRNA to β-actin mRNA 
was determined using the 2-∆Ct method (18). Each 
assay was done in duplicate. 
Statistical analyzes 
In statistics, normality tests were used to 
determine whether a data set is well-modeled by a 
normal distribution or not. Cytokine expression is 
presented as means and differences between 
infected and uninfected groups were analyzed using 
the Mann-Whitney test. P values<0.05 were 
considered as significant. 
 
Results 
Genotype analysis 
Table 1 gives an overview of the frequency 
distribution of the cagA, babA2 status. The babA2 
gene was found in 49.5% of the H. pylori positive 
biopsies (Table 1). The cagA gene was detected in 
68.3% (69 biopsies) of H. pylori positive 
specimens. The frequency of virulence factors in H. 
pylori positive biopsies is shown in table 2. 
 
Table 1. Frequency of the cagA and the babA2 in studied patients 
Genotype Frequency N                                                             % 
cagA 
Positive 
Negative 
69                                                          68.3 
32                                                          31.7 
babA2 
positive 
negative 
50                                                           49.5 
51                                                          50.5  
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Fig. 1 . Mucosal IL-33 mRNA expression level in gastritis patients. 79 H. pylori infected and 51 H. pylori non-infected patients with 
gastritis were analyzed for IL-33 expression by real-time PCR. Levels are normalized to β-actin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elevated IL-33 expression in H. pylori-infected 
gastric mucosa 
IL-33 mRNA level was detectable in all 
samples regardless of whether biopsies were taken 
from H. pylori-infected or uninfected patients. IL-
33 expression was significantly higher in biopsy 
specimens of H. pylori-infected patients compared 
with uninfected patients (P<0.0001) (Fig. 1). If the 
mean H. pylori-positive group is 0.0069 and the 
mean H. pylori-negative group is 0.0008 then the 
difference in the IL-33 mRNA expression in the H. 
pylori-positive compared with the H. pylori-
negative patients is 0.0069/0.0008 or 8.6 fold. 
Effect of cagA and babA2 on the mucosal IL-33 
mRNA levels in H. pylori-infected patients 
A mucosal IL-33 mRNA level was dependent 
on virulence factors status. If the mean level of IL-
33 in H. pylori-cagA positive group is 0.00798 and 
the mean level of IL-33 in H. pylori-cagA negative 
group is 0.0079, then the difference in the IL-33 
mRNA expression in the cagA-positive H. Pylori 
strains in comparison with the cagA-negative H. 
pylori strains biopsies is 0.00798/0.0079 or 1.01 
fold. The difference in the IL-33 mRNA expression 
in the babA2-positive H. pylori strains compared 
with the babA2-negative H. pylori strains is 
0.0067/0.0012 or 5.58 fold (Fig. 2). 
Association between mucosal IL-33 mRNA levels 
and gastric inflammation classification  
During this study, semi-quantitative methods 
of scoring according to the updated Sydney system 
were used. The degree of active inflammation was 
evaluated and scored as below: 19.8% mild, 24.8% 
moderate and 19.8% severe, and more than 64% of 
gastritis patients were in an active stage of H. pylori 
gastritis. In addition the degree of chronic 
inflammation was assessed and graded as follow: 
11.9% mild, 13.9% moderate, 9.9% severe, and 
Table 2. Frequency of virulence factors in H. pylori positive biopsies 
                  Genotype
 
              Frequency 
cagA babA2 N (%) 
+ + 43 62.3 
+ - 26 37.7 
- + 7 21.9 
- - 25 78.1 
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Fig. 2. Mucosal IL-33 mRNA expression in H. pylori infected patients according to virulence factors. IL-33 mRNA expression level was 
significantly lower in babA2 negative gastritis patients compared with babA2 positive patients. There is no significant relationship between 
IL-33 gene expression and existence of cagA virulence factor. 
Fig. 3. Mucosal IL-33 mRNA levels according to gastritis status. IL-33 mRNA expression level was significantly lower in chronic gastritis 
patients compared with patients with active gastritis. 
more than 35% of gastritis patients were in a 
chronic phase of H. pylori gastritis (Table 3). 
Association between mucosal IL-33 mRNA levels 
and type of gastritis 
Figure 3 shows the relationship between the 
mucosal IL-33 mRNA expression and chronic 
inflammation (mononuclear cell infiltration) scores. 
There was a significant correlation between the 
mucosal IL-33 mRNA expression and the active 
inflammation scores (P<0.001). If the mean of IL-
33 mRNA level in chronic gastritis group is 0.0031 
and the mean of IL-33 mRNA level in active 
gastritis group is 0.0083 then the difference in the 
IL-33 mRNA expression in the active gastritis 
compared with the chronic gastritis biopsies is 
0.0083/0.0031 or 2.67 fold (Fig. 3). 
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Table. 3. H.pylori gastritis status according to updated Sydney classification 
Description Mild 
N (%) 
Moderate 
N (%) 
Severe 
N (%) 
Total 
N (%) 
Active 
 
14 (19.8) 18 (24.8) 14 (19.8) 46 (64.4) 
Chronic 
(no activity) 
8 (11.6) 10 (14) 7 (10) 25 (35.6) 
H.pylori positive 
 
all all all all 
Man/woman 
 
10/12 14/14 9/12 33/38 
Total 22 (30.99) 28 (39.44) 
 
21 (29.57) 
 
71 (100) 
 
Discussion  
H. pylori infection may remain in the host for 
a long time and H. pylori pathogenesis is related to 
its virulence factors including cagA and babA. 
The cagA positivity in Iranian isolates varies 
between 44% to 91% in different reports. In the 
present study, 68.3% of the patients were infected 
with cagA- positive strains, similar to other Iranian 
reports (1, 19, 20). The babA positivity in Iranian 
isolates has been reported to vary from 40.6% to 
94% in different studies. In the present study, 
49.5% of the patients were infected with babA-
positive strains, similar to other Iranian reports (1, 
21, 22).The IL-1 family of cytokines has an 
established role in immune regulation and 
inflammatory processes. IL-33 has been observed 
to supply protection during gastric infection and 
may be an important mediator of the immune 
functions after damage or infection in epithelial 
cells (23, 24). IL-33 has been reported to reduce 
colonization and pathological effects in 
gastrointestinal infection (25). Recently several 
researches suggested that IL-33 may be involved in 
tumorogenesis and development of vascular 
diseases (26). In the present study, IL-33 mRNA 
expression was significantly higher in H. pylori 
infected patients than non-infected patients. Similar 
to our results, in another study in 2015, IL-33 
mRNA expression increased with bacterial 
infection in stomach (27). However, in another 
study in 2015, IL-33 mRNA expression was 
reduced in chronic infection by H. pylori (14). In 
the present study, IL-33 mRNA expression was 
significantly high in babA2 positive H. Pylori 
infected patients as well as active gastritis patients. 
To the best of our knowledge, this report is the first 
study considering the association between IL-33 
mRNA expression and virulence factors. Like our 
results, another study in 2015 showed that IL-33 
mRNA expression was increased in active gastritis 
biopsies more than chronic gastritis samples (14). 
The expression levels of other cytokines from IL-1 
family such as IL-18 was higher in H. pylori-
positive patients and cagA+ infected patients 
compared with H. pylori-negative patients and 
cagA negative infected patients(28). The results of 
a study in 2013, showed that there was no 
association between virulence factors and IL-18 
mRNA expression (29). Another study showed that 
serum levels of IL-33 were significantly higher in 
patients with gastric cancer than healthy people, 
suggesting that serum IL-33 levels may have a 
closer correlation with gastric cancer than IL-18 
levels. In other words, elevated serum IL-33 level 
was found to be an independent prognostic 
indicator (30). Stimulation through both Toll-Like 
receptors (TLRs) and Nod-Like receptors (NLRs) 
are all required for processing and release of IL-18 
and IL-33 from normal monocytes (31). Similarly, 
in another study, elevated IL-33 mRNA expression 
was detected only in lipopolysaccharide (LPS)- 
activated monocytes (5). LPSs from Escherichia 
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coli stimulate host immune cells via TLR4 and 
TLR2 and enhance IL-33 gene expression level in 
monocytes (32-34). Some data suggest that 
engagement of both TLR2 and TLR4 pathways 
stimulates IL-33 indicating a potential role for this 
cytokine in immune responses to diverse pathogens 
and pathogen associated microbial patterns 
(PAMPs) (35). 
Our data suggest that reduction in IL-33 
mRNA expression level may be a biomarker for 
predicting the prognosis of gastritis, especially in 
chronic gastritis which is an initiation for gastric 
ulcer. Prospective studies in a larger population and 
more virulence factors should be carried out to 
confirm the findings. 
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